EGFR and colorectal cancer: As the reasons for the heterogeneity of response of colorectal cancer cells to EGFR-targeted therapies, and the rapid emergence of chemotherapy-resistant strains, are still poorly understood15 these nanoparticles have been used for preliminary investigation of biodistribution and uptake in a murine xenograft colorectal cancer model.